Extended ABO blood group A antigen structures (Extended A antigen)

Extended ABO blood group A antigen structures are complex carbohydrate molecules found on the surface of red blood cells, epithelial cells, and in various biological secretions. These structures are formed by the action of the A-transferase enzyme (encoded by the ABO gene), which adds an N-acetylgalactosamine (GalNAc) residue to the H-antigen precursor. The term 'extended' refers to the various underlying core chains (Type 1 through 4) and repetitive carbohydrate motifs that can increase the complexity and length of the antigen, influencing its density and accessibility on the cell surface. These antigens play a critical role in transfusion medicine and organ transplantation, as individuals lacking the A-antigen possess naturally occurring anti-A antibodies that can trigger life-threatening immune responses upon exposure. Beyond their role in hematology, extended A-antigen structures are significant in oncology and infectious disease. Altered expression of these glycans, such as the loss of A-antigen or the expression of incompatible A-like antigens, is frequently observed in various carcinomas and is associated with tumor progression and metastasis. Furthermore, these structures serve as attachment receptors for several pathogens, including certain strains of Norovirus and Helicobacter pylori. Therapeutic strategies involving these antigens include the development of enzymatic 'blood conversion' technologies to create universal donor blood and the use of monoclonal antibodies or desensitization protocols to facilitate ABO-incompatible organ transplants.

Other names

Blood group A carbohydrate antigenA-determinantType 1/2/3/4 A-antigen structuresGalNAc-alpha-1,3-(Fuc-alpha-1,2)-Gal-beta-RHisto-blood group A antigen

Antibodies (isoagglutinins) bind to the A-antigen on cell surfaces, triggering the complement cascade and leading to hemolysis or cell lysis. In enzymatic conversion, glycosidases cleave the terminal GalNAc residue to convert A-type cells into O-type cells.